Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Cancer Discovery|June 3, 2024
Optimus-Era Dose Finding for Rare CancersYonina R Murciano-Goroff, Sean M Devlin, Alexia Iasonos, et al.
Thrombosis Research|April 29, 2018
Predictive factors of fatal bleeding in acute promyelocytic leukemiaSimon Mantha, Martin S Tallman, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Second autologous stem cell transplant: an effective therapy for relapsed multiple myelomaKamal Kant Singh Abbi, Junting Zheng, Sean M Devlin, et al.
Tissue Engineering. Part A|July 10, 2018
A Bilayered Poly (Lactic-Co-Glycolic Acid) Scaffold Provides Differential Cues for the Differentiation of Dental Pulp Stem CellsRiddhi A Gangolli, Sean M Devlin, Jonathan A Gerstenhaber, et al.
The American Journal of Managed Care|May 13, 2008
Complementary and alternative medicine provider use and expenditures by cancer treatment phaseWilliam E Lafferty, Patrick T Tyree, Sean M Devlin, et al.
Leukemia Research|February 27, 2018
Widespread use of measurable residual disease in acute myeloid leukemia practiceZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.
Blood|January 27, 2017
Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysisMark B Geyer, Meier Hsu, Sean M Devlin, et al.
Health and Quality of Life Outcomes|August 9, 2007
Quality of life at the end of lifePaula Diehr, William E Lafferty, Donald L Patrick, et al.
Annals of Hematology|August 21, 2016
Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemiaSamantha N Reiss, Larry W Buie, Nelly Adel, et al.
Journal of Women'S Health (2002)|February 17, 2010
Identification of ovarian cancer symptoms in health insurance claims dataSean M Devlin, Paula H Diehr, M Robyn Andersen, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Cancer Discovery|June 3, 2024
Optimus-Era Dose Finding for Rare CancersYonina R Murciano-Goroff, Sean M Devlin, Alexia Iasonos, et al.
Thrombosis Research|April 29, 2018
Predictive factors of fatal bleeding in acute promyelocytic leukemiaSimon Mantha, Martin S Tallman, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Second autologous stem cell transplant: an effective therapy for relapsed multiple myelomaKamal Kant Singh Abbi, Junting Zheng, Sean M Devlin, et al.
Tissue Engineering. Part A|July 10, 2018
A Bilayered Poly (Lactic-Co-Glycolic Acid) Scaffold Provides Differential Cues for the Differentiation of Dental Pulp Stem CellsRiddhi A Gangolli, Sean M Devlin, Jonathan A Gerstenhaber, et al.
The American Journal of Managed Care|May 13, 2008
Complementary and alternative medicine provider use and expenditures by cancer treatment phaseWilliam E Lafferty, Patrick T Tyree, Sean M Devlin, et al.
Leukemia Research|February 27, 2018
Widespread use of measurable residual disease in acute myeloid leukemia practiceZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.
Blood|January 27, 2017
Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysisMark B Geyer, Meier Hsu, Sean M Devlin, et al.
Health and Quality of Life Outcomes|August 9, 2007
Quality of life at the end of lifePaula Diehr, William E Lafferty, Donald L Patrick, et al.
Annals of Hematology|August 21, 2016
Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemiaSamantha N Reiss, Larry W Buie, Nelly Adel, et al.
Journal of Women'S Health (2002)|February 17, 2010
Identification of ovarian cancer symptoms in health insurance claims dataSean M Devlin, Paula H Diehr, M Robyn Andersen, et al.
Pageof 18